Asia Pacific Long Read Sequencing Market
No. of Pages: 130 | Report Code: TIPRE00024446 | Category: Life Sciences
No. of Pages: 130 | Report Code: TIPRE00024446 | Category: Life Sciences
Asia Pacific long read sequencing market comprises China, India, Japan, South Korea, Australia, Singapore, and rest of Asia Pacific. The growth of the market is attributed to the increasing investments by the governments in the region. The rise in the development and research for the genomics. In addition, the initiatives by the government of India for the startups in biotechnology sectors are likely to foster the growth of the long read sequencing market in the country. In China, the demand for DNA sequencing is fueled by the country’s growing middle class, aging population, and expanding healthcare system. Many companies are investing huge money into research in the country. Illumina will provide sequencing systems, reagents, and genomics expertise and will help outfit laboratory space, while the investment firm will help connect new companies and founders with entrepreneurs and financial advice, as well as provide at least US$500,000 in upfront funding. Also, Biotechnology is set to become a key driver of economic and social development in China, increasing the adoption of the long read sequencing market. Thus, owing to these advancements, the long read sequencing market expected to grow at a rapid pace in the forecast period. Growth in funding for genomics is the major factor driving the growth of the Europe long read sequencing market.
In January 2020, after a series of pneumonia cases in Wuhan, the Chinese health authorities, the capital city of Hubei province (China), announced that a novel coronavirus, officially known as severe acute respiratory syndrome coronavirus (SARS-CoV)-2, was responsible for these cases. In mid-January 2020, researchers in China and Australia published the whole genome sequence of SARS-CoV-2. The genomics helped understand SARS-CoV-2, which enabled governments and researchers to track the emergence of Covid-19 outbreaks in their country. The World Health Organization demands an increase in genomic sequencing of the coronavirus after the detection of the new virus strain. For instance, in India, the health ministry has installed the Indian SARS-CoV-2 Genomics Consortium (INSACOG) for laboratory and epidemiological surveillance and develops the virus's whole-genome sequencing, helping in understanding the virus transmission and evolution. Market players realized the importance of genomics in the treatment of COVID 19, which is expected to raise demand for genomic during the forecast period. For instance, the Singapore-incorporated medtech company Cell ID Pte. Ltd. developed a palm-sized portable genetic test kit that uses an app on a laptop to detect, anywhere, anytime, if a person is affected COVID-19. Dubbed the Quiz PCR Biochip, the test uses biotechnology to perform two tests at a t
Strategic insights for the Asia Pacific Long Read Sequencing provides data-driven analysis of the industry landscape, including current trends, key players, and regional nuances. These insights offer actionable recommendations, enabling readers to differentiate themselves from competitors by identifying untapped segments or developing unique value propositions. Leveraging data analytics, these insights help industry players anticipate the market shifts, whether investors, manufacturers, or other stakeholders. A future-oriented perspective is essential, helping stakeholders anticipate market shifts and position themselves for long-term success in this dynamic region. Ultimately, effective strategic insights empower readers to make informed decisions that drive profitability and achieve their business objectives within the market.
| Report Attribute | Details |
|---|---|
| Market size in 2021 | US$ 250.33 Million |
| Market Size by 2028 | US$ 1,095.21 Million |
| Global CAGR (2021 - 2028) | 23.5% |
| Historical Data | 2019-2020 |
| Forecast period | 2022-2028 |
| Segments Covered |
By Technology
|
| Regions and Countries Covered | Asia-Pacific
|
| Market leaders and key company profiles |
The geographic scope of the Asia Pacific Long Read Sequencing refers to the specific areas in which a business operates and competes. Understanding local distinctions, such as diverse consumer preferences (e.g., demand for specific plug types or battery backup durations), varying economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved areas or adapting their offerings to meet local demands. A clear market focus allows for more effective resource allocation, targeted marketing campaigns, and better positioning against local competitors, ultimately driving growth in those targeted areas.
The long read sequencing market in APAC is expected to grow from US$ 250.33 million in 2021 to US$ 1,095.21 million by 2028; it is estimated to grow at a CAGR of 23.5% from 2021 to 2028. Long-read technologies are overcoming early limitations of accuracy and throughput and mounting their application in the fields of genomics. Long read sequencing or third-generation sequencing offers several advantages over short-read sequencing. While short-read sequencers such as Illumina’s HiSeq, NovaSeq, NextSeq, and MiSeq instruments, BGI’s MGISEQ and BGISEQ models; or Thermo Fisher’s Ion Torrent sequencers produce reads of up to 600 bases, long read sequencing technologies regularly generate reads over 10 kb.Further, long reads can improve de novo assembly, mapping certainty, transcript isoform identification, and detection of structural variants. Also, long read sequencing of native molecules, i.e., DNA and RNA eliminates amplification bias while preserving base modifications. With continuing progress in accuracy, throughput, and cost reduction, these capabilities have begun to make long read sequencing an option for a broad range of applications in genomics for model and non-model organisms.
The Europe long read sequencing market is segmented based on technology, product, application, workflow and end user, and country. Based on technology, the long read sequencing market is sub-segmented into single-molecule real-time sequencing (SMRT), nanopore sequencing, and loop genomics long-read sequencing. The single-molecule real-time sequencing (SMRT) segment dominated the market in 2020 and loop genomics long-read sequencing segment is expected to be the fastest growing during the forecast period. Based on product, the long read sequencing market is categorized into instruments, consumables, and services. The consumables segment dominated the market in 2020 and services segment is expected to be the fastest growing during the forecast period. Based on application, the market is segmented into identification and fine mapping of structural variation, tandem repeat sequencing, pseudogene discrimination, resolving allele phasing, reproductive genomics, cancer, viral and microbial sequencing. The identification and fine mapping of structural variation segment dominated the market in 2020 and cancer segment is expected to be the fastest growing during the forecast period. Based on workflow, the market is segmented pre-sequencing, sequencing, and data analysis. The sequencing segment dominated the market in 2020 and is expected to be the fastest growing during the forecast period. Based on end user, the long read sequencing market is sub-segmented into academic research institutes, hospitals and clinics, and pharma and biotechnology companies. The academic research institutes, hospitals and clinics segment dominated the market in 2020 and is expected to be the fastest growing during the forecast period.
A few major primary and secondary sources referred to for preparing this report on the long read sequencing market in Europe are company websites, annual reports, financial reports, national government documents, and statistical database, among others. Major companies listed in the report are Bionano Genomics; F. HOFFMANN-LA ROCHE LTD.; Illumina, Inc.; Longas Technologies; Oxford Nanopore Technologies; Pacific Biosciences of California, Inc.; and PerkinElmer, Inc. are among others.
The Asia Pacific Long Read Sequencing Market is valued at US$ 250.33 Million in 2021, it is projected to reach US$ 1,095.21 Million by 2028.
As per our report Asia Pacific Long Read Sequencing Market, the market size is valued at US$ 250.33 Million in 2021, projecting it to reach US$ 1,095.21 Million by 2028. This translates to a CAGR of approximately 23.5% during the forecast period.
The Asia Pacific Long Read Sequencing Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Asia Pacific Long Read Sequencing Market report:
The Asia Pacific Long Read Sequencing Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The Asia Pacific Long Read Sequencing Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the Asia Pacific Long Read Sequencing Market value chain can benefit from the information contained in a comprehensive market report.
Office No. 1011, First floor, Farena Corporate Park, Magarpatta-Mundhwa road, Pune - 411028, Maharashtra, India
UK+442030260021, US:+16467917070
sales@businessmarketinsights.com
Get Free Sample For Asia Pacific Long Read Sequencing Market
